DIFFERENCE BETWEEN R5020 AND THE ANTIPROGESTIN RU486 IN ANTIPROLIFERATIVE EFFECTS ON BREAST-CANCER CELLS - REPLY

被引：0
作者：
GILL, P
VIGNON, F
ROCHEFORT, H
机构：
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1988年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 4 条
  • [1] BOUTON MM, 1987, BIOCH BIOPHYS RES CO, V146, P1502
  • [2] DIFFERENCE BETWEEN R5020 AND THE ANTIPROGESTIN RU486 IN ANTIPROLIFERATIVE EFFECTS ON HUMAN-BREAST CANCER-CELLS
    GILL, PG
    VIGNON, F
    BARDON, S
    DEROCQ, D
    ROCHEFORT, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 37 - 45
  • [3] HENDERSON BE, 1985, CANCER, V56, P1206, DOI 10.1002/1097-0142(19850901)56:5<1206::AID-CNCR2820560541>3.0.CO
  • [4] 2-9
1